| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8446312 | European Journal of Cancer | 2012 | 7 Pages |
Abstract
Our results show that CVP is an effective chemotherapy regimen in children and adolescents with early stage nLPHL that is well tolerated with minimal acute toxicity.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
![Treatment outcome after low intensity chemotherapy [CVP] in children and adolescents with early stage nodular lymphocyte predominant Hodgkin's lymphoma - An Anglo-French collaborative report](/preview/png/8446312.png "First Page Preview: Treatment outcome after low intensity chemotherapy [CVP] in children and adolescents with early stage nodular lymphocyte predominant Hodgkin's lymphoma - An Anglo-French collaborative report")
Authors
Ananth Shankar, Georgina W. Hall, Stephanie Gorde-Grosjean, Dirk Hasenclever, Thierry Leblanc, Janis Hayward, Anne Lambilliotte, Stephen Daw, Yves Perel, Keith McCarthy, Odile Lejars, Aurore Coulomb, W. Odile Oberlin, W. Hamish Wallace,